HLA-A and neoplasm: Additionally, aberrantly glycosylated forms of MUC16 may reduce the presentation of tumor-specific peptides via HLA-A and HLA-B molecules, enabling tumor cells to escape immune system recognition and facilitating tumor immune evasion, thus promoting tumor cell survival, proliferation, growth, and metastasis within the immune microenvironment (209).